TL;DR
- What they are: Two synthetic peptides developed by the Russian Academy of Sciences in the 1980s–90s. Selank is a synthetic analog of tuftsin. Semax is a fragment of ACTH (4-10) modified for stability.
- Mechanism: Both modulate BDNF and NGF expression in the brain, but via different upstream pathways. Selank works heavily on GABAergic and serotonergic tone (anxiolysis). Semax works on dopaminergic, melanocortin, and BDNF pathways (cognitive enhancement).
- Who they’re for: High-performers running chronic cognitive load, anyone with anxiety that isn’t responding to lifestyle interventions, people who want stimulant-like focus without the amphetamine downside, recovery from cognitive burnout.
- Differentiator: Approved as prescription pharmaceuticals in Russia for over a decade. Better human safety data than most underground nootropics. Intranasal delivery — no needles.
- Natural Plus angle: Pulse-dosed for acute use, not daily indefinite. The goal is to break maladaptive neural patterns and let baseline neuroplasticity carry the gains forward.
Why Almost Nobody in the West Talks About These
Most Western nootropic discussion is stuck on the same handful of compounds — racetams, modafinil, L-theanine, caffeine, lion’s mane. Meanwhile, the Russian Academy of Sciences developed an entire class of synthetic peptide drugs starting in the 1980s, ran them through real Phase III trials, got them approved as prescription medications, and has prescribed them to millions of Russians for decades. We mostly ignore them because the original literature is in Russian and the compounds aren’t marketed in the US.
I’ve been running selank and semax on and off since 2021. They’re not in the same league as a heavy stimulant for raw cognitive output, but they’re not trying to be. What they do is recalibrate the system — Selank takes the edge off chronic anxiety without sedation, Semax pulls you out of cognitive fog without the jitters. The intranasal delivery is fast (effects in 5–15 minutes) and convenient.
I use Semax in writing blocks when I need 4 hours of deep focus and don’t want to burn dopamine the way modafinil does. I use Selank before high-stakes conversations or shoots where I want to be present without being tight. Both compounds have a quality you don’t get from American nootropics: clean.
Deep Biochemistry
Selank — The Tuftsin Analog
Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro — a heptapeptide derived from tuftsin (a natural immunomodulatory peptide) with a glycine-proline extension that prevents enzymatic cleavage. It crosses the blood-brain barrier rapidly via intranasal delivery.
Mechanistically, Selank does several things simultaneously. It increases BDNF expression in the hippocampus and cortex (the master neurotrophic factor for new neural growth and synaptic plasticity). It modulates GABAergic tone, producing anxiolysis without the sedation, addiction, or memory impairment seen with benzodiazepines — this is the major selling point. It elevates serotonin and norepinephrine turnover modestly, contributing to mood stabilization. And it has documented immunomodulatory effects via its tuftsin parentage, which is part of why early Russian clinical trials looked at it for both anxiety and immune-mediated conditions.
Half-life intranasal: roughly 30 minutes to 1 hour for the peptide itself, but BDNF-mediated effects persist 24–72 hours after single administration. This is part of why pulse dosing works.
Semax — The ACTH(4-10) Fragment
Semax is Met-Glu-His-Phe-Pro-Gly-Pro — the heptapeptide derived from amino acids 4-10 of adrenocorticotropic hormone (ACTH), with a C-terminal Pro-Gly-Pro tail added for stability. The key insight: ACTH(4-10) has well-known cognitive effects in animal studies without the HPA-axis-activating effects of full-length ACTH. Semax preserves the cognitive activity and adds metabolic stability.
Semax upregulates BDNF and NGF in the brain, with particularly strong effects in the hippocampus. It modulates the dopaminergic system in the prefrontal cortex, which is the substrate for the focus and motivation effects. It interacts with the melanocortin system (MC4R) — this overlaps with PT-141’s mechanism and is part of why Semax has subtle effects on motivation and arousal. It has documented neuroprotective effects in stroke models — Semax is actually approved in Russia for acute ischemic stroke treatment.
Half-life intranasal: roughly 15–30 minutes for the peptide, but the BDNF/NGF upregulation persists for hours to days.
Tony Huge Laws of Biochemistry Physics: Law 2 — Chain Optimization
This is the Tony Huge Laws of Biochemistry Physics, Law 2 in textbook form: Chain Optimization. Cognitive performance is a chain — neurotransmitter synthesis, receptor sensitivity, neurotrophic support, baseline neuroplasticity, and downstream behavioral output. Most nootropics push one link harder and hope the rest of the chain holds up. Stimulants flood the synapse with dopamine and norepinephrine — but if your BDNF is low or your receptors are downregulated, the flood doesn’t help much.
Selank and Semax work upstream. They increase neurotrophic factors (BDNF, NGF) that strengthen the entire chain. They modulate neurotransmitter tone rather than flooding the synapses. They preserve baseline regulation — your brain remains a self-regulating system rather than getting stuck in a high-output state. This is why the effects feel “clean” and why the comedown is mild — you’re upgrading the chain, not maxing out one link.
The assembly-line analogy: stimulants speed up one station. selank and semax retrain every station to run faster. The first approach is fast and unstable. The second is slower but durable.
Natural Plus Protocol
Selank Protocol
- Form: 0.15% nasal spray (typical compounded preparation). Each spray delivers approximately 250–300mcg.
- Dose: 2–3 sprays per nostril, 1–2 times daily as needed. Total daily: 1000–1800mcg.
- Timing: Morning for general daily anxiety baseline. As-needed before high-anxiety events. Avoid within 4 hours of sleep — the cognitive activation can interfere with sleep onset for some users.
- Cycle: 14–21 days on, 7+ days off. Or pulse-dose 2–3 times per week indefinitely.
- Side effects: Minimal at therapeutic doses. Mild nasal irritation. Occasionally a brief headache 30 minutes in. No sedation, no impairment, no addiction potential documented.
Semax Protocol
- Form: 0.1% or 1% nasal spray. Standard is 0.1% — start there. Each spray of 0.1% delivers approximately 250mcg.
- Dose: 2–4 sprays per nostril, 1–2 times daily depending on goal. Cognitive enhancement: 600–1000mcg morning. Neuroprotection / recovery: lower doses, 300–600mcg.
- Timing: Morning, before deep work. Optionally a second dose at noon for extended cognitive sessions. Do NOT dose after 3pm — sleep disruption likely.
- Cycle: 14 days on, 7 days off. Or as-needed for acute cognitive demands.
- Side effects: Mild headache (most common), occasional brief jitteriness, rare nasal irritation. Sleep disruption if dosed too late. No documented addiction or tolerance issues.
Combined Use
Selank and Semax can be combined. Most users dose them at different times — Semax morning (focus), Selank as-needed (anxiolysis). Combined morning dosing is fine for high-performers running both cognitive load and anxiety load simultaneously.
Stacking Recommendations
| Compound | Pathway | Why It Synergizes |
|---|---|---|
| L-Tyrosine (500mg) | Dopamine precursor | Provides substrate for the dopamine release Semax is signaling for. Otherwise, you’re shouting at an empty pantry. |
| Lion’s Mane (1g) | NGF induction (oral, slower) | Different upstream route to NGF. Stacks well long-term without receptor competition. |
| Caffeine (100–200mg) | Adenosine antagonism | Independent pathway to alertness. Stacks cleanly with Semax for an additive focus boost. |
| Magnesium L-threonate | NMDA receptor modulation | Different cognitive pathway. Particularly helpful if memory consolidation is the goal. |
Target Audience
These peptides are built for chronic cognitive load. Operators, writers, founders, traders, and creatives whose work demands sustained attention. People with mild-to-moderate anxiety who don’t want to take SSRIs or benzos. Anyone recovering from cognitive burnout — chronic stress states downregulate BDNF, and Semax/Selank can help reset that. Knowledge workers over 40 starting to notice declining baseline cognitive output. Not for psychiatric conditions requiring clinical intervention — see a physician for those.
Timeline — What to Expect
| Timeframe | What to Expect |
|---|---|
| 5–15 min post-dose | Subtle mental shift. Semax: focus tightens, internal chatter quiets. Selank: tension drops without sedation. |
| 1–4 hours post-dose | Peak effect. Semax produces a “flow-state friendly” focus — extended deep work feels easier. Selank produces a calm, present, socially comfortable baseline. |
| After 1 week | Baseline begins to shift even on off-doses. Anxiety ceiling lower. Cognitive recovery between sessions faster. Sleep often improves. |
| After 2–3 weeks | BDNF-mediated structural changes accrue. Some users report the gains persist into the off-cycle — the brain has re-learned a higher-functioning baseline. |
Interesting Perspectives
The BDNF crossover with exercise. Both Selank and Semax upregulate BDNF. So does intense exercise. So does intermittent fasting. So does cold exposure. The compound here is that BDNF is the master regulator of neuroplasticity, and almost everything that improves cognition long-term works partly through this pathway. The peptides aren’t doing something exotic — they’re efficiently activating a pathway your other lifestyle interventions also touch. Stacking them with the lifestyle factors is more effective than treating either as the whole solution.
The stroke recovery angle. Semax is approved in Russia for acute ischemic stroke. The neuroprotective data is significant — reduced infarct size, faster functional recovery. This suggests off-label applications I find compelling: post-concussion recovery (athletes), cognitive rehabilitation after extended high-stress periods, recovery from COVID-related cognitive symptoms. The mechanism (BDNF upregulation, anti-inflammatory effects in CNS) translates across these scenarios.
Contrarian take: most “racetam” stacks should be replaced. The classic Western nootropic stack — piracetam, aniracetam, oxiracetam — has weak human evidence and unclear mechanisms. Selank and Semax have stronger mechanistic models, better human safety data (real Phase III trials in Russia), and faster onset via intranasal delivery. If you’re running a racetam stack, swap it for Selank/Semax and see what happens. Most people don’t go back.
The motivation effect of Semax. Past the cognitive enhancement, Semax has a documented effect on motivation that isn’t well-characterized in the literature. Users often describe it as “wanting to do the work” rather than “feeling stimulated to do the work.” This is consistent with the dopaminergic mesolimbic effects but qualitatively different from amphetamine-class compounds. It’s one of the more interesting subjective profiles in the nootropic space.
FAQ
What are Selank and Semax?
Selank and Semax are synthetic peptides developed by the Russian Academy of Sciences in the 1980s–90s. Selank (a tuftsin analog) is used for anxiolysis without sedation. Semax (an ACTH 4-10 fragment) is used for cognitive enhancement and neuroprotection. Both are approved prescription medications in Russia and are delivered intranasally.
How do Selank and Semax compare to modafinil or Adderall?
Different mechanism and different outcome profile. Modafinil and amphetamines acutely flood the brain with neurotransmitter activity — high output, real comedown, possible tolerance. Selank and Semax upregulate neurotrophic factors (BDNF, NGF) and modulate neurotransmitter tone — lower acute intensity, cleaner comedown, longer-lasting baseline shift. Best used as complements to lifestyle factors, not as direct substitutes for prescription stimulants.
Are Selank and Semax safe?
Both have multi-decade human use as approved prescription medications in Russia, with documented safety profiles in clinical populations. No addiction potential, no significant withdrawal, no meaningful organ toxicity at therapeutic doses. Most common side effect: mild headache or nasal irritation. Not recommended during pregnancy or for under-18s due to limited data in those populations.
How do I dose Selank and Semax?
Both are intranasal sprays. Selank: 2–3 sprays per nostril of 0.15% solution, 1–2 times daily, cycled 14–21 days on with 7 days off. Semax: 2–4 sprays per nostril of 0.1% solution, morning only (avoid afternoon dosing — sleep disruption), cycled 14 days on with 7 days off.
Can I stack Selank and Semax?
Yes. They target different aspects of cognitive function (anxiolysis vs focus/motivation) via partially independent pathways. Most users dose Semax in the morning for cognitive enhancement and Selank as-needed for anxiolysis. Combined morning dosing is also viable for users running both high cognitive load and high anxiety load.
Related Reading
- Nootropics Hub on Tony Huge
- More on BDNF and neuroplasticity
- Modafinil — the traditional Western nootropic alternative
- All peptide content on Tony Huge
- Anxiety management without benzos or SSRIs
References
- Kost NV et al. “μ- and δ-Opioid Receptor Antagonist Activities of Selank, a Peptide Anxiolytic.” Bull Exp Biol Med, 2001.
- Medvedev VE et al. “Optimization of therapy of patients with anxiety-asthenic disorders by intranasal peptide drug Selank.” Zh Nevrol Psikhiatr Im S S Korsakova, 2014.
- Asmarin IP et al. “ACTH (4-10) and its modified analog Semax: experimental and clinical applications.” Patol Fiziol Eksp Ter, 2007.
- Kaplan AY et al. “Synthetic ACTH analogue Semax displays nootropic-like activity in humans.” Neurosci Res Commun, 1996.
- Gusev EI, Skvortsova VI, Miasoedov NF et al. “Effectiveness of semax in acute ischemic stroke.” Zh Nevrol Psikhiatr Im S S Korsakova, 1997.
- Volkova A et al. “Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission.” Front Pharmacol, 2016. DOI: 10.3389/fphar.2016.00031
- Shadrina M et al. “Comparative analysis of expression of serotonergic and dopaminergic genes in the rat brain under conditions of administration of Selank and Semax peptides.” Mol Biol, 2013.
About Tony Huge
Tony Huge is a self-experimenter, biohacker, and founder of Enhanced Labs. He has spent over a decade researching and personally testing peptides, SARMs, anabolic compounds, nootropics, and longevity protocols. Tony’s mission is to push the boundaries of human potential through science, transparency, and direct experience. Follow his research at tonyhuge.is.
Related reading
- Selank and Semax: the russian nootropic peptides that actually work
- Selank and Semax: the russian nootropic Peptides That Put Smart Drugs to Shame
- Semax: the russian nootropic Peptide That Outperforms Modafinil For Sustained Focus